CODEXIS, INC. (CDXS)

1.69 0.04 (2.42%)

As of 2025-12-02 08:27:46 EST

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

Traded asNasdaq: CDXS
ISINUS1920051067
CIK0001200375
LEI549300KGLM6CDPTVSE20
EIN710872999
SectorProtein engineering
IndustryIndustrial Organic Chemicals
CEOStephen Dilly, Ph.D.
Employees165
Fiscal Year End1231
Address200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063
Phone650-421-8100
Websitehttp://codexis.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
CDXSCODEXIS, INC.2025-12-02 08:27:461.690.042.42
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
CDXS0001200375CODEXIS, INC.US1920051067549300KGLM6CDPTVSE20710872999Nasdaq2860Industrial Organic Chemicals1231DE200 PENOBSCOT DRIVEREDWOOD CITYCA94063UNITED STATESUS650-421-8100200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063200 PENOBSCOT DRIVE, REDWOOD CITY, CA, 94063CODEXIS INCProtein engineering2002Stephen Dilly, Ph.D.165http://codexis.com152,400,00090,281,00090,324,383Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.2025-11-27 18:59:06
This is a preview of the latest data. Subscribe to access the full data.
CDXS Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
CDXS Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024152,400,00030,000,00024.509882,837,31112,533,67217.8279
2023122,400,000-261,400,000-68.108470,303,6394,356,8326.6066
2022383,800,000-353,700,000-47.959365,946,807786,1281.2064
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Kevin NorrettChief Operating Officer2024474,4850159,668237,24214,8401,518,851
Alison MooreChief Technical Officer, Executive Vice President2024115,3820248,49857,69171,5861,102,937
Stephen DillyChief Executive Officer, Director, President, Chairman Of The Board2024713,5500437,446535,16353,8003,472,920
Georgia ErbezChief Financial Officer2024115,3820148,50057,691240931,593
Sriram RyaliChief Financial Officer2024354,2020159,668173,812163,3791,483,677
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024188
2023174
2022248
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue59,345,00070,143,000138,590,000
Cost Of Revenue16,288,00012,809,00038,033,000
Gross Profit———
Research And Development Expenses46,263,00058,885,00080,099,000
General And Administrative Expenses55,148,00053,250,00052,172,000
Operating Expenses117,864,000138,212,000173,471,000
Operating Income-58,519,000-68,069,000-34,881,000
Net Income-65,276,000-76,240,000-33,592,000
Earnings Per Share Basic-0.89-1.12-0.51
Earnings Per Share Diluted-0.89-1.12-0.51
Weighted Average Shares Outstanding Basic73,408,00068,131,00065,344,000
Weighted Average Shares Outstanding Diluted73,408,00068,131,00065,344,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents19,264,00065,116,000113,984,000
Marketable Securities Current54,194,000——
Accounts Receivable4,375,00010,036,00031,904,000
Inventories1,799,0002,685,0002,029,000
Non Trade Receivables———
Other Assets Current500,000600,000—
Total Assets Current98,772,00093,466,000162,894,000
Marketable Securities Non Current———
Property Plant And Equipment14,197,00015,487,00022,614,000
Other Assets Non Current1,019,0001,246,000350,000
Total Assets Non Current43,098,00028,624,00061,877,000
Total Assets149,011,000136,561,000250,393,000
Accounts Payable2,838,0005,947,0003,246,000
Deferred Revenue350,0003,781,00013,728,000
Short Term Debt0——
Other Liabilities Current6,223,0004,735,00015,279,000
Total Liabilities Current23,648,00035,830,00049,066,000
Long Term Debt28,905,000——
Other Liabilities Non Current1,268,0001,233,0001,371,000
Total Liabilities Non Current58,436,00014,116,00056,530,000
Total Liabilities82,084,00049,946,000105,596,000
Common Stock8,0007,0006,000
Retained Earnings-562,806,000-497,530,000-421,290,000
Accumulated Other Comprehensive Income52,000——
Total Shareholders Equity66,927,00086,615,000144,797,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization4,946,0005,518,0005,402,000
Share Based Compensation Expense13,087,0009,971,00014,531,000
Other Non Cash Income Expense——29,000
Change In Accounts Receivable———
Change In Inventories-886,000656,000869,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable-2,567,0002,287,000207,000
Change In Other Liabilities——5,983,000
Cash From Operating Activities-49,410,000-52,638,00011,284,000
Purchases Of Marketable Securities90,235,000——
Sales Of Marketable Securities1,973,000——
Acquisition Of Property Plant And Equipment4,305,0004,418,0008,307,000
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-56,980,000-4,858,000-13,578,000
Tax Withholding For Share Based Compensation0404,0001,488,000
Payments Of Dividends———
Issuance Of Common Stock31,319,0008,652,0000
Repurchase Of Common Stock———
Issuance Of Long Term Debt29,521,000——
Repayment Of Long Term Debt———
Other Financing Activities———
Cash From Financing Activities60,522,0008,167,000-575,000
Change In Cash-45,868,000-49,329,000-2,869,000
Cash At End Of Period19,264,00065,116,000113,984,000
Income Taxes Paid17,000194,000100,000
Interest Paid2,566,00044,00034,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-0.89-1.12-0.51
Price To Earnings Ratio-5.3596-2.7232-9.1373
Earnings Growth Rate-20.5357119.607854.5455
Price Earnings To Growth Ratio0.261-0.0228-0.1675
Book Value Per Share0.91171.27132.2159
Price To Book Ratio5.23192.39912.103
Ebitda-56,813,000-70,528,000-28,090,000
Enterprise Value359,797,160——
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.4319——
Capital Expenditures3,656,000-1,609,0006,671,000
Free Cash Flow-53,066,000-51,029,0004,613,000
Return On Equity-0.9753-0.8802-0.232
One Year Beta1.98772.68121.8894
Three Year Beta2.05832.03341.419
Five Year Beta1.5561.51971.4092
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Opaleye Management Inc.10% owner2025-12-01245,000D9,955,000
Opaleye Management Inc.10% owner2025-12-018,533D179,989
Opaleye Management Inc.10% owner2025-11-28105,000D10,200,000
Opaleye Management Inc.10% owner2025-11-282,490D188,522
Opaleye Management Inc.10% owner2025-11-26148,318A10,305,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Lamar Smith2018-05-08TX21Purchase2018-04-06—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
JPMORGAN CHASE & CO2025-09-3093,53938,3362.44
CIBC Private Wealth Group LLC2025-09-304,3921,8002.44
JACOBS LEVY EQUITY MANAGEMENT, INC2025-09-302,842,2241,164,8462.44
Arax Advisory Partners2025-09-308,6113,5292.4401
AQR CAPITAL MANAGEMENT LLC2025-09-30205,12984,0692.44
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
RYDEX SERIES FUNDS2025-09-30Class CRYCMX115280.60.0042
RYDEX SERIES FUNDS2025-09-30Class ARYAKX115280.60.0042
RYDEX SERIES FUNDS2025-09-30Class HRYMKX115280.60.0042
RYDEX SERIES FUNDS2025-09-30Class HRYRHX192468.480.0038
RYDEX SERIES FUNDS2025-09-30Class CRYROX192468.480.0038
This is a preview of the latest data. Subscribe to access the full data.